PubRank

S Eddahibi

Author PubWeight™ 26.38‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension. Eur Respir J 2005 1.98
2 Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest 1991 1.91
3 Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice. Circulation 2005 1.84
4 5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension. Br J Pharmacol 2000 1.42
5 Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension. Eur Respir J 2001 1.15
6 Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 2000 1.13
7 Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats. Am J Respir Cell Mol Biol 2000 1.12
8 Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension. Eur Respir J 2006 1.11
9 Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension. Eur Respir J 2009 1.11
10 Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension. Am J Physiol 1998 1.10
11 Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. J Clin Invest 1994 1.07
12 Inhibition of matrix metalloproteinases by lung TIMP-1 gene transfer or doxycycline aggravates pulmonary hypertension in rats. Circ Res 2000 1.01
13 Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension. Am J Respir Cell Mol Biol 2000 1.00
14 Tryptophan hydroxylase 1 knockout and tryptophan hydroxylase 2 polymorphism: effects on hypoxic pulmonary hypertension in mice. Am J Physiol Lung Cell Mol Physiol 2007 0.92
15 Effects of inhaled nitric oxide or inhibition of endogenous nitric oxide formation on hyperoxic lung injury. Am J Respir Crit Care Med 1997 0.86
16 NO in the lung. Respir Physiol 1995 0.83
17 Loss of endothelium-dependent relaxation in proximal pulmonary arteries from rats exposed to chronic hypoxia: effects of in vivo and in vitro supplementation with L-arginine. J Cardiovasc Pharmacol 1993 0.83
18 Cardiac and lung VEGF mRNA expression in chronically hypoxic and monocrotaline-treated rats. Chest 1998 0.83
19 Endothelin dilates bovine pulmonary circulation and reverses hypoxic pulmonary vasoconstriction. J Cardiovasc Pharmacol 1992 0.82
20 Lessons from oncology to understand and treat pulmonary hypertension. Int J Clin Pract Suppl 2007 0.81
21 Pulmonary vascular response to endothelin in rats. J Appl Physiol (1985) 1991 0.79
22 Pulmonary vasodilatory action of endogenous atrial natriuretic factor in rats with hypoxic pulmonary hypertension. Effects of monoclonal atrial natriuretic factor antibody. Circ Res 1992 0.78
23 Induction of cardiac nitric oxide synthase 2 in rats exposed to chronic hypoxia. J Mol Cell Cardiol 1999 0.78
24 Adenovirus-mediated atrial natriuretic protein expression in the lung protects rats from hypoxia-induced pulmonary hypertension. Hum Gene Ther 2001 0.77
25 Endothelins and pulmonary hypertension, what directions for the near future? Eur Respir J 2001 0.76
26 Induction of nitric oxide synthase activity in pulmonary arteries from normoxic and chronically hypoxic rats. Eur Respir J 1997 0.75
27 Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats. Eur Respir J 2009 0.75
28 Decreased endothelium-dependent pulmonary vasodilator effect of calcitonin gene-related peptide in hypoxic rats contrasts with increased binding sites. Eur Respir J 1995 0.75
29 [Nitric oxide, from vascular physiology to therapeutics]. Arch Mal Coeur Vaiss 1994 0.75
30 Nitric oxide in the pulmonary circulation. Monaldi Arch Chest Dis 1996 0.75